Exploring the Multi-Target Performance of Mitochondriotropic Antioxidants against the Pivotal Alzheimer’s Disease Pathophysiological Hallmarks

Exploring the Multi-Target Performance of Mitochondriotropic Antioxidants against the Pivotal Alzheimer’s Disease Pathophysiological Hallmarks

Alzheimer disease (AD) is the most common neurodegenerative disease featuring progressive and degenerative neurological impairments resulting in memory loss and cognitive decline. The specific mechanisms underlying AD are still poorly understood, but it is suggested that a deficiency in the brain ne...

Full description

Bibliographic Details
Main Authors:	Sofia Benfeito, Carlos Fernandes, Santiago Vilar, Fernando Remião, Eugenio Uriarte, Fernanda Borges
Format:	Article
Language:	English
Published:	MDPI AG 2020-01-01
Series:	Molecules
Subjects:	alzheimer disease mitochondriotropic antioxidants cholinesterase inhibitors oxidative stress β-amyloid iron accumulation excitotoxicity
Online Access:	https://www.mdpi.com/1420-3049/25/2/276

Similar Items

Cytotoxicity and Mitochondrial Effects of Phenolic and Quinone-Based Mitochondria-Targeted and Untargeted Antioxidants on Human Neuronal and Hepatic Cell Lines: A Comparative Analysis
by: Carlos Fernandes, et al.
Published: (2021-10-01)

Hydroxybenzoic Acid Derivatives as Dual-Target Ligands: Mitochondriotropic Antioxidants and Cholinesterase Inhibitors
by: Catarina Oliveira, et al.
Published: (2018-04-01)

Fine-Tuning the Biological Profile of Multitarget Mitochondriotropic Antioxidants for Neurodegenerative Diseases
by: Daniel Chavarria, et al.
Published: (2021-02-01)

A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients
by: Cláudia M. Deus, et al.
Published: (2021-09-01)

Development of Bioactive Molecules for the Treatment of Alzheimer’s Disease
by: Amisha Punmiya, et al.
Published: (2022-11-01)

Phenolic composition, antioxidant activity, anticholinesterase potential and modulatory effects of aqueous extracts of some seaweeds on β-amyloid aggregation and disaggregation
by: Tosin A. Olasehinde, et al.
Published: (2019-01-01)

Targeting the molecular web of Alzheimer’s disease: unveiling pathways for effective pharmacotherapy
by: Devika Jadhav, et al.
Published: (2024-01-01)

The therapeutic value of thiazole and thiazolidine derivatives in Alzheimer's disease: a systematic literature review
by: Zahra Abdollahi, et al.
Published: (2024-01-01)

Macroalgae as a Valuable Source of Naturally Occurring Bioactive Compounds for the Treatment of Alzheimer’s Disease
by: Tosin A. Olasehinde, et al.
Published: (2019-10-01)

CHOLINESTERASE INHIBITORS IN THE TREATMENT OF DEMENTIA ALZHEIMER’S
by: Prameidya Primaniar S
Published: (2013-03-01)

Position Statement on Anti-Dementia Medication for Alzheimer’s Disease by Swiss Stakeholders
by: Giovanni B Frisoni, et al.
Published: (2021-08-01)

New Multitarget Rivastigmine–Indole Hybrids as Potential Drug Candidates for Alzheimer’s Disease
by: Leo Bon, et al.
Published: (2024-02-01)

Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission?
by: Verkhratsky Alexei, et al.
Published: (2011-07-01)

Homomeric and Heteromeric Aβ Species Exist in Human Brain and CSF Regardless of Alzheimer’s Disease Status and Risk Genotype
by: Erica Lana, et al.
Published: (2019-07-01)

The role of trace elements in Alzheimer's disease
by: Sujeetha Purushothaman, et al.
Published: (2020-01-01)

Effects of Linkers and Substitutions on Multitarget Directed Ligands for Alzheimer’s Diseases: Emerging Paradigms and Strategies
by: Narayanaperumal Pravin, et al.
Published: (2022-05-01)

Astrocytes as a Therapeutic Target in Alzheimer’s Disease–Comprehensive Review and Recent Developments
by: Mateo Rodríguez-Giraldo, et al.
Published: (2022-11-01)

Discovery of a new mitochondria permeability transition pore (mPTP) inhibitor based on gallic acid
by: José Teixeira, et al.
Published: (2018-01-01)

Pathophysiological Ionotropic Glutamate Signalling in Neuroinflammatory Disease as a Therapeutic Target
by: Richard Fairless, et al.
Published: (2021-10-01)

Alcohol Use Disorder, Neurodegeneration, Alzheimer’s and Parkinson’s Disease: Interplay Between Oxidative Stress, Neuroimmune Response and Excitotoxicity
by: Haziq Kamal, et al.
Published: (2020-08-01)

Management of moderate to severe Alzheimer’s disease: Focus on memantine
by: Evangelyn Dominguez, et al.
Published: (2011-12-01)

Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management of Alzheimer’s disease
by: Faisal Imam, et al.
Published: (2024-05-01)

Anti-Cholinesterase Combination Drug Therapy as a Potential Treatment for Alzheimer’s Disease
by: Hafsa Amat-ur-Rasool, et al.
Published: (2021-02-01)

Uptake of Aβ by OATPs might be a new pathophysiological mechanism of Alzheimer disease
by: Jinhua Wen, et al.
Published: (2021-09-01)

Alzheimer’s disease: A Threat to mankind
by: Poorti Pandey, et al.
Published: (2011-12-01)

Flavonoids as Prospective Neuroprotectants and Their Therapeutic Propensity in Aging Associated Neurological Disorders
by: Muhammad Ayaz, et al.
Published: (2019-06-01)

Neuroprotective and Anti-Aging Potentials of Essential Oils from Aromatic and Medicinal Plants
by: Muhammad Ayaz, et al.
Published: (2017-05-01)

Pathophysiology of Alzheimer’s Disease
by: Mohammad Amani
Published: (2017-01-01)

Molecular mechanisms of neurodegeneration in the entorhinal cortex that underlie its selective vulnerability during the pathogenesis of Alzheimer's disease
by: Olayemi Joseph Olajide, et al.
Published: (2021-01-01)

Preventive Role of Indian Black Pepper in Animal Models of Alzheimer’s Disease
by: Lokraj Subedee, et al.
Published: (2015-04-01)

Exploiting the Chalcone Scaffold to Develop Multifunctional Agents for Alzheimer’s Disease
by: Angela Rampa, et al.
Published: (2018-07-01)

The protective effect of Indian Catechu methanolic extract against aluminum chloride-induced neurotoxicity, A rodent model of Alzheimer's disease
by: Ekramy Elmorsy, et al.
Published: (2021-02-01)

The specific features of using a rivastigmine transdermal formulation in Alzheimer’s disease
by: Elena Evgenyevna Vasenina, et al.
Published: (2012-09-01)

Imaging Alzheimer's disease pathophysiology with PET
by: Lucas Porcello Schilling, et al.

Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis
by: Dominik Glinz, et al.
Published: (2019-06-01)

Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer’s disease agents
by: Sheunopa C. Mzezewa, et al.
Published: (2021-01-01)

Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease
by: Nadine El Tannir El Tayara, et al.
Published: (2006-04-01)

New treatment approaches for the management of Alzheimer's disease
by: Abhishek, et al.
Published: (2022-06-01)

Ligand-based pharmacophore modeling to identify plant-derived acetylcholinesterase inhibitor natural compounds in Alzheimer’s disease
by: saeed pirmoradi
Published: (2023-07-01)

Galantamine plasma concentration and cognitive response in Alzheimer’s disease
by: Yi-Ting Lin, et al.
Published: (2019-05-01)